Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial

BACKGROUND: Visceral leishmaniasis (VL) is a major health problem in developing countries. The untreated disease is fatal, available treatment is expensive and often toxic, and drug resistance is increasing. Improved treatment options are needed. Paromomycin was shown to be an efficacious first-line...

Descripción completa

Detalles Bibliográficos
Autores principales: Hailu, Asrat, Musa, Ahmed, Wasunna, Monique, Balasegaram, Manica, Yifru, Sisay, Mengistu, Getahun, Hurissa, Zewdu, Hailu, Workagegnehu, Weldegebreal, Teklu, Tesfaye, Samson, Makonnen, Eyasu, Khalil, Eltahir, Ahmed, Osama, Fadlalla, Ahmed, El-Hassan, Ahmed, Raheem, Muzamil, Mueller, Marius, Koummuki, Yousif, Rashid, Juma, Mbui, Jane, Mucee, Geoffrey, Njoroge, Simon, Manduku, Veronica, Musibi, Alice, Mutuma, Geoffrey, Kirui, Fredrick, Lodenyo, Hudson, Mutea, Dedan, Kirigi, George, Edwards, Tansy, Smith, Peter, Muthami, Lawrence, Royce, Catherine, Ellis, Sally, Alobo, Moses, Omollo, Raymond, Kesusu, Josephine, Owiti, Rhoda, Kinuthia, John
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964287/
https://www.ncbi.nlm.nih.gov/pubmed/21049059
http://dx.doi.org/10.1371/journal.pntd.0000709

Ejemplares similares

Ejemplares similares